<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116138">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097368</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00601-44</org_study_id>
    <nct_id>NCT02097368</nct_id>
  </id_info>
  <brief_title>Bulbar Function in Neuromuscular Patients</brief_title>
  <acronym>ORDEG</acronym>
  <official_title>Prospective Evaluation of Bulbar Function in Neuromuscular Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <authority>France: National Consultative Ethics Committee for Health and Life Sciences</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is prospectively study the upper airways function in an adult population
      of neuromuscular patients. The main measurement will be the evolution of tongue strength
      recorded each year during annual clinical evaluation on a 5 years period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to study the function of the superior airways (tongue and pharynx) in
      an non invasive way in neuromuscular patients followed in the home ventilation unit of the
      Raymond POINCARE hospital  (myopathy, neuropathy, disease of the neuromuscular junction or
      anterior horn) and to detect prematurely the bulbar dysfunction.

      The secondary objectives of this prospective monocentric observational physiopathological
      study are:

        1. to study the correlation between the possible swallowing dysfunction and the anomalies
           of the respiratory parameters

        2. to establish correlations between infraclinical or clinical and presence of
           morphological tongue anomalies detected by magnetic resonance imaging like in acid
           maltase deficiency.

      The maximal tongue strength protrusion will be measured according to a method already used
      in the laboratory to explore sleep apnea syndromes.

      Swallowing  will be estimated by a non invasive method already used to highlight swallowing
      disorders  in neurological and muscular pathologies This method will be associated with a
      method of recording of thoracic and abdominal movements.

      Data wil be compared to a control database obtained for a previous study
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change of tongue strength measurement</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement using mechanical force transducer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>swallowing tests</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Non invasive measurement of swallowing function using surface electromyography, accelerometry and inductance plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory parameters</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Vital capacity and respiratory muscle strength measurement using spirometry and manometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscle strength</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>manometry (maximal inspiratory pressure and expiratory pressure)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <arm_group>
    <arm_group_label>neuromuscular patient</arm_group_label>
    <description>Patients affected by neuromuscular pathology will be explored by tongue strength measurement, respiratory function measurement, swallowing tests and Magnetic resonance imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tongue strength measurement</intervention_name>
    <description>tongue strength measurement</description>
    <arm_group_label>neuromuscular patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>respiratory function measurement</intervention_name>
    <description>respiratory function measurement</description>
    <arm_group_label>neuromuscular patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>swallowing tests</intervention_name>
    <description>swallowing tests</description>
    <arm_group_label>neuromuscular patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic resonance imaging</intervention_name>
    <description>Magnetic resonance imaging</description>
    <arm_group_label>neuromuscular patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients affected by neuromuscular pathology
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  neuromuscular disorder

          -  age greater than or equal to 18

          -  Hospitalization in Home Ventilation Unit of the intensive care department of R
             POINCARE Hospital

          -  Written informed consent

        Exclusion Criteria:

          -  patient's refusal to participate

          -  major swallowing disfunction

          -  Acute respiratory failure

          -  no affiliation to social security
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Orlikowski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique et Technologique 805</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helene Prigent, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique et Technologique 805</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederic Lofaso, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique et Technologique 805</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Orlikowski, MD PhD</last_name>
    <phone>33147107777</phone>
    <email>david.orlikowski@rpc.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frederic Barbot, MD</last_name>
    <phone>33147104474</phone>
    <email>frederic.barbot@rpc.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Home Ventilation Unit, Raymond Poincare Hospital</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Orlikowski, MD, PhD</last_name>
      <phone>33 1 47 10 77 77</phone>
      <email>david.orlikowski@rpc.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marjorie Figere, CRA</last_name>
      <phone>33147104615</phone>
      <email>marjorie.figere@rpc.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>David Orlikowski, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helene Prigent, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frederic Lofaso, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tongue strength</keyword>
  <keyword>neuromuscular</keyword>
  <keyword>swallowing</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
